Acute effects of oval calcium load on parathyroid function and on bone resorption in young men

被引:12
作者
Guillemant, J [1 ]
Le, HT [1 ]
Maria, A [1 ]
Guillemant, S [1 ]
机构
[1] Fac Med Pitie Salpetriere, Serv Biochim Med, F-75634 Paris 13, France
关键词
biological markers; collagen; parathormone; calcium;
D O I
10.1159/000013555
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aim: The aime of the present study was to check whether a calcium oral load was able to inhibit bone resorption as assessed by urinary excretion of a new bone marker, type 1 collagen cross-linked C-telopeptide (CrossLaps(TM)), in healthy young male adults. Methods: Twenty healthy young male adults (age 22 +/- 2 years) were studied. In one series of assays, an oral calcium load of 1 g of elemental calcium as calcium citrate dissolved in 200 ml of low-calcium water was ingested, while in another series of assays the subjects ingested 200 mi of water alone. Blood samples were collected before and 1, 2, 3 and 4 h after the intake of calcium. Urine was collected at 2-hour intervals, i.e. before and for 4 h after the intake of calcium. Serum ionized calcium, phosphate and intact parathormone (iPTH) were measured at each time point. Urinary calcium, phosphate, creatinine and CrossLaps (as a ratio to creatinine) were measured in each urine sample. Results: Calcium intake was associated with very significant (ANOVA, p < 0.001) increases in serum ionized calcium and decreases in PTH. After calcium intake, measurements of urinary CrossLaps showed a progressive statistically significant (ANOVA, p < 0.001) decrease (-20% at 2 h and -55% at 4 h), whereas after ingestion of water, the changes were modest and not statistically significant. Conclusions: The present results show that bone resorption as assessed by urinary excretion of CrossLaps can be significantly suppressed by the ingestion of a 1-gram calcium load and attest that calcium supplementation has an acute effect on bone metabolism. Copyright (C) 2000 S. Karger AG. Basel.
引用
收藏
页码:48 / 52
页数:5
相关论文
共 9 条
[1]   OPTIMAL CALCIUM INTAKE [J].
BILEZIKIAN, JP ;
BAILEY, L ;
ELMER, PJ ;
FAVUS, MJ ;
GO, VLW ;
GOLDRING, SR ;
HOLT, LH ;
INSOGNA, KL ;
KRIMGOLD, B ;
MALLETTE, LE ;
SHAPIRO, JR ;
STJEOR, ST ;
STERN, PH ;
TILLEY, BC ;
YAMAMOTO, ME .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (24) :1942-1948
[2]  
GARNERO P, 1995, J BONE MINER RES, V10, P641
[3]   COMPARISON OF THE SUPPRESSIVE EFFECT OF 2 DOSES (500 MG VS 1500 MG) OF ORAL CALCIUM ON PARATHYROID-HORMONE SECRETION AND ON URINARY CYCLIC-AMP [J].
GUILLEMANT, J ;
GUILLEMANT, S .
CALCIFIED TISSUE INTERNATIONAL, 1993, 53 (05) :304-306
[4]   ORAL CALCIUM SUPPRESSES BIOCHEMICAL MARKERS OF BONE-RESORPTION IN NORMAL MEN [J].
HOROWITZ, M ;
WISHART, JM ;
GOH, D ;
MORRIS, HA ;
NEED, AG ;
NORDIN, BEC .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1994, 60 (06) :965-968
[5]  
NEED AG, 1991, EUR J CLIN NUTR, V45, P357
[6]   CALCIUM BIOAVAILABILITY FROM CALCIUM-CARBONATE AND CALCIUM CITRATE [J].
NICAR, MJ ;
PAK, CYC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 61 (02) :391-393
[7]   ACUTE BIOCHEMICAL VARIATIONS INDUCED BY 4 DIFFERENT CALCIUM SALTS IN HEALTHY MALE-VOLUNTEERS [J].
REGINSTER, JY ;
DENIS, D ;
BARTSCH, V ;
DEROISY, R ;
ZEGELS, B ;
FRANCHIMONT, P .
OSTEOPOROSIS INTERNATIONAL, 1993, 3 (05) :271-275
[8]  
RUBINACCI A, 1996, J ENDOCRINOL INVEST, V19, P718
[9]  
ZERWEKH JE, 1981, INVEST UROL, V19, P161